Latest filing published 17 Jul 2026 for Mannkind CORP, €38k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Christopher B. Prentiss span 2 companies, the busiest being Adamas Pharmaceuticals Inc and Mannkind Corp. Over a trading history stretching from 6 October 2017 to 15 July 2026, the count stands at 27 filings.
Every open-market trade on record is a sale: 9 sales worth €81k. The rest of the record consists of 17 share grants.
The newest entry dates from 17 July 2026: a share grant of €41k, in Mannkind Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations